Ashraf Mohamed

Dr. Ashraf Mohamed

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2006 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
Abd El-Galil Elsayed AmrAbd El-Galil Elsayed Amr
Abd El-Galil Elsayed Amr
AMAshraf Mohamed
Ashraf Mohamed
SMSalwa F. Mohamed
Salwa F. Mohamed
MEMohamed Abdelwahab Elsayed
Mohamed Abdelwahab Elsayed
AHAbu El-Fotooh G. Hammam
Abu El-Fotooh G. Hammam

20 January 2017 in Molecules
Verified
Journal Article
Open access
PDF file
EFEman Flefel
Eman Flefel
WEWael A. El-Sayed
Wael A. El-Sayed
AMAshraf Mohamed
Ashraf Mohamed
WEWalaa I. El-Sofany
Walaa I. El-Sofany
HAHanem Awad
Hanem Awad
New 1-thia-azaspiro[4.5]decane derivatives, their derived thiazolopyrimidine and 1,3,4-thiadiazole compounds were synthesized. The thioglycoside derivatives of the synthesized (1,3,4-thiadiazolyl)thiaazaspiro[4.5]decane and thiazolopyrimidinethione compounds were synthesized by glycosylation reactions using acetylated glycosyl bromides. The anticancer activity of synthesized compounds was studied against the cell culture of HepG-2 (human liver hepatocellular carcinoma), PC-3 (human prostate adenocarcinoma) and HCT116 (human colorectal carcinoma) cell lines and a number of compounds showed moderate to high inhibition activities.

1 September 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BYBahaa G. M. Youssif
Bahaa G. M. Youssif
AMAshraf Mohamed
Ashraf Mohamed
EOEssam Eldin A. Osman
Essam Eldin A. Osman
OAOla F. Abou-Ghadir
Ola F. Abou-Ghadir
DEDina H. Elnaggar
Dina H. Elnaggar
HGHesham Gomaa
Hesham Gomaa

1 September 2003 in Zeitschrift für Naturforschung B
Verified
Journal Article
Closed access
PDF file
Abd El-Galil Elsayed AmrAbd El-Galil Elsayed Amr
Abd El-Galil Elsayed Amr
AMAshraf Mohamed
Ashraf Mohamed
AIAlhussein A. Ibrahim
Alhussein A. Ibrahim
A series of chiral macrocyclic pyridines has been prepared starting from N2,N2-(pyridine- 2,6-dicarbonyl)diamino acid hydrazides (2a-c) and N,N-bis-(1-carboxy-2-substituted)-2,6- diaminocarbonyl)pyridines (3a,b). The coupling of (2a-c) with 2,6-pyridine dicarbonyldichloride (4) gave the compounds (5a-c). Compounds 2a-c were coupled with 2,6-diacetylpyridine (6) to yield compounds (7a-c) and with heterocyclic aldehydes (8) or (10) to give the compounds (9a-c) or (11a-c). In addition, the hydrazides (2a-c) were reacted with diformylcalix[4]arene 12 to afford the macrocyclic calix[4]arene hydrazone derivatives (13a-c) in reasonable yields. Finally, reaction of diaminocalix-[4]arene derivatives (14a,b) with hydrazides 2a,b or acids (3a,b), using azide or mixed anhydride methods afforded macrocyclic calix[4]arene derivatives 15a,b and 16a,b, respectively. The structure assignments of the new compounds are based on chemical and spectroscopic evidence. The biological activity screening tests showed that many of the obtained compounds exhibit high antimicrobial activity comparable to ampicillin and chloramphenicol which are used as reference compounds.

23 August 2010 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
AEAymn Elzeny
Aymn Elzeny
WEWael A. El-Sayed
Wael A. El-Sayed
AMAshraf Mohamed
Ashraf Mohamed
MHMamdouh Moawad Ali Hassan
Mamdouh Moawad Ali Hassan

11 May 2007 in Monatshefte für Chemie - Chemical Monthly
Verified
Journal Article
Closed access
PDF file
NANehad A. Abdel-Latif
Nehad A. Abdel-Latif
NSNermien M. Sabry
Nermien M. Sabry
AMAshraf Mohamed
Ashraf Mohamed
MAMohamed M. Abdulla
Mohamed M. Abdulla